Summary
Bristol-Myers Squibb Company (BMY) filed an 8-K on October 22, 2009, to announce its financial results for the third quarter of 2009. This filing primarily serves to furnish a press release and supplemental financial information, providing investors with key performance metrics and operational updates for the period. While the 8-K itself does not contain the detailed financial figures, it directs investors to the attached press release (Exhibit 99.1) and additional data on the company's website (Exhibit 99.2) for a comprehensive understanding of the company's performance. Investors should review these attached documents to assess BMY's revenue, profitability, and any significant business developments during the third quarter of 2009.
Key Highlights
- 1Bristol-Myers Squibb (BMY) announced its third-quarter 2009 financial results on October 22, 2009.
- 2The 8-K filing serves as notification of the release of these financial results.
- 3Exhibit 99.1 includes the official press release detailing the Q3 2009 financial performance.
- 4Exhibit 99.2 provides supplemental financial information available on the company's website.
- 5Investors are directed to these exhibits for in-depth financial data and operational highlights.
- 6The filing indicates the period covered is the third quarter of 2009.
Frequently Asked Questions
The primary purpose of this 8-K filing is to officially announce and provide access to Bristol-Myers Squibb's financial results for the third quarter of 2009. It serves as a notification mechanism for investors and the public.
The detailed financial results and commentary are primarily contained within the press release furnished as Exhibit 99.1 to this 8-K filing. Additional supplemental information can be found on the company's website at www.bms.com, provided as Exhibit 99.2.
Investors should look for key financial metrics such as revenue, earnings per share (EPS), net income, operating income, and any guidance or outlook provided by the company. Additionally, important business updates, product news, or strategic developments relevant to the third quarter should be noted.